Date Filer Title Filing Type Shares Traded Price Total Held
Apr 23, 2021
Chief Medical Officer
Chief Medical Officer Form 3/A Amendment to an Initial Statement of Beneficial Ownership of Securities 10,210 -- --
Apr 01, 2021
Chief Medical Officer
Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 275,000 -- 275,000
Apr 01, 2021
Director, President and CEO
Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 775,000 -- 775,000
Apr 01, 2021
Chief Operating Officer
Chief Operating Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 275,000 -- 275,000
Apr 01, 2021
Chief Financial Officer
Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 275,000 -- 275,000
Jan 22, 2021
Chief Financial Officer
Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,000 $6.00 8,000
Sep 03, 2020
Chief Medical Officer
Chief Medical Officer Form 3 Initial Statement of Beneficial Ownership of Securities -- -- --
Sep 03, 2020
Chief Financial Officer
Chief Financial Officer Form 3 Initial Statement of Beneficial Ownership of Securities -- -- --
Sep 01, 2020
Chief Medical Officer
Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 300,000 -- 300,000
Sep 01, 2020
Chief Medical Officer
Chief Medical Officer Form 4/A Grant, award or other acquisition pursuant to Rule 16b-3(d) 300,000 -- 300,000

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.